LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 504

Search options

  1. Article ; Online: Single high-energy arc proton therapy with Bragg peak boost (SHARP).

    Penfold, Scott N / Santos, Alexandre M C / Penfold, Melanie / Shierlaw, Emma / Crain, Rosanna

    Journal of medical radiation sciences

    2024  Volume 71 Suppl 2, Page(s) 27–36

    Abstract: Introduction: Because of the co-location of critical organs at risk, base of skull tumours require steep dose gradients to achieve the prescribed dosimetric criteria. When available, proton beam therapy (PBT) is often considered a desirable modality for ...

    Abstract Introduction: Because of the co-location of critical organs at risk, base of skull tumours require steep dose gradients to achieve the prescribed dosimetric criteria. When available, proton beam therapy (PBT) is often considered a desirable modality for these cases, but in many instances, compromises in target coverage are still required to achieve critical organ at risk (OAR) tolerance doses. A number of techniques have been proposed to further improve the penumbra of PBT. In the current study, we propose a novel, collimator-free treatment planning technique that combines high-energy shoot-through proton beams with conventional Bragg peak spot placement. The small spot size of the high-energy pencil beams provides a sharp penumbra at the target boundary, and the Bragg peak spots provide a higher linear energy transfer (LET) boost to the target centre.
    Methods: Three base of skull chordoma patients were retrospectively planned with three different PBT treatment planning techniques: (1) conventional intensity-modulated proton therapy (IMPT); (2) high-energy proton arc therapy (HE-PAT); and (3) the novel technique combining HE-PAT and IMPT, referred to as single high-energy arc with Bragg peak boost (SHARP). The Monaco 6 treatment planning system was used.
    Results: SHARP was found to improve the PBT penumbra in the plane perpendicular to the HE-PAT beams. Minimal penumbra differences were observed in the plane of the HE-PAT beams. SHARP reduced dose-averaged LET to surrounding organs at risk.
    Conclusion: A novel PBT treatment planning technique was successfully implemented. Initial results indicate the potential for SHARP to improve the penumbra of PBT treatments for base of skull tumours.
    MeSH term(s) Humans ; Proton Therapy ; Protons ; Radiotherapy Dosage ; Retrospective Studies ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated/methods ; Neoplasms
    Chemical Substances Protons
    Language English
    Publishing date 2024-02-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2734841-6
    ISSN 2051-3909 ; 2051-3909
    ISSN (online) 2051-3909
    ISSN 2051-3909
    DOI 10.1002/jmrs.769
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Dosimetric comparison of gantry and horizontal fixed-beam proton therapy treatment plans for base of skull chordoma.

    Shierlaw, Emma / Penfold, Melanie / Crain, Rosanna / Santos, Alexandre M C / Penfold, Scott N

    Journal of medical radiation sciences

    2023  Volume 71 Suppl 2, Page(s) 19–26

    Abstract: Introduction: Australia's first proton beam therapy (PBT) centre will house a fixed-beam room and two gantry rooms. As the only PBT facility in Australia for at least the short term, there is a need to efficiently allocate treatment appointments between ...

    Abstract Introduction: Australia's first proton beam therapy (PBT) centre will house a fixed-beam room and two gantry rooms. As the only PBT facility in Australia for at least the short term, there is a need to efficiently allocate treatment appointments between the gantry and fixed-beam rooms. This planning study assesses the dosimetric differences between fixed-beam and gantry-based treatment plans for base of skull chordoma, one of the core indications likely to be referred for PBT in Australia.
    Methods: Retrospective gantry-based and fixed-beam treatment plans were generated for five patients with base of skull chordoma. Fixed-beam plans were generated with a conventional horizontal patient positioning system. Robust intensity modulated proton therapy (IMPT) optimisation and evaluation techniques were used for both delivery systems. Plans were designed to maximise target coverage while adhering to maximum dose constraints to neighbouring critical organs at risk.
    Results: Robust target coverage and integral dose were found to be approximately equivalent for the gantry-based and fixed-beam plans. Doses to specific organs at risk could be reduced with the gantry-based geometry; however, the gantry-based plans did not exhibit a general decrease in doses to organs at risk.
    Conclusion: A fixed-beam treatment plan was found to be non-inferior to a gantry-based treatment plan for all base of skull patients included in the current study.
    MeSH term(s) Humans ; Proton Therapy ; Chordoma/radiotherapy ; Retrospective Studies ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated/methods ; Skull Base ; Radiotherapy Dosage ; Organs at Risk
    Language English
    Publishing date 2023-12-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2734841-6
    ISSN 2051-3909 ; 2051-3909
    ISSN (online) 2051-3909
    ISSN 2051-3909
    DOI 10.1002/jmrs.742
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.

    Atila, Cihan / Gaisl, Odile / Vogt, Deborah R / Werlen, Laura / Szinnai, Gabor / Christ-Crain, Mirjam

    European journal of endocrinology

    2022  Volume 187, Issue 1, Page(s) 65–74

    Abstract: ... at the University Hospital Basel, Switzerland.: Methods: Each participant underwent the glucagon test (s.c. injection of 1 ...

    Abstract Background: The differential diagnosis of diabetes insipidus is challenging. The most reliable approaches are copeptin measurements after hypertonic saline infusion or arginine, which is a known growth hormone secretagogue but has recently also been shown to stimulate the neurohypophysis. Similar to arginine, glucagon stimulates growth hormone release, but its effect on the neurohypophysis is poorly studied.
    Design: Double-blind, randomized, placebo-controlled trial including 22 healthy participants, 10 patients with central diabetes insipidus, and 10 patients with primary polydipsia at the University Hospital Basel, Switzerland.
    Methods: Each participant underwent the glucagon test (s.c. injection of 1 mg glucagon) and placebo test. The primary objective was to determine whether glucagon stimulates copeptin and to explore whether the copeptin response differentiates between diabetes insipidus and primary polydipsia. Copeptin levels were measured at baseline, 30, 60, 90, 120, 150, and 180 min after injection.
    Results: In healthy participants, glucagon stimulated copeptin with a median increase of 7.56 (2.38; 28.03) pmol/L, while placebo had no effect (0.10 pmol/L (-0.70; 0.68); P < 0.001). In patients with diabetes insipidus, copeptin showed no relevant increase upon glucagon, with an increase of 0.55 (0.21; 1.65) pmol/L, whereas copeptin was stimulated in patients with primary polydipsia with an increase of 15.70 (5.99; 24.39) pmol/L. Using a copeptin cut-off level of 4.6pmol/L had a sensitivity of 100% (95% CI: 100-100) and a specificity of 90% (95% CI: 70-100) to discriminate between diabetes insipidus and primary polydipsia.
    Conclusion: Glucagon stimulates the neurohypophysis, and glucagon-stimulated copeptin has the potential for a safe, novel, and precise test in the differential diagnosis of diabetes insipidus.
    MeSH term(s) Arginine ; Diabetes Insipidus/diagnosis ; Diabetes Mellitus/diagnosis ; Diagnosis, Differential ; Glucagon ; Glycopeptides ; Growth Hormone ; Humans ; Polydipsia, Psychogenic/diagnosis
    Chemical Substances Glycopeptides ; copeptins ; Growth Hormone (9002-72-6) ; Glucagon (9007-92-5) ; Arginine (94ZLA3W45F)
    Language English
    Publishing date 2022-05-12
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1183856-5
    ISSN 1479-683X ; 0804-4643
    ISSN (online) 1479-683X
    ISSN 0804-4643
    DOI 10.1530/EJE-22-0033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.

    Choudhary, Manish C / Crain, Charles R / Qiu, Xueting / Hanage, William / Li, Jonathan Z

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2021  Volume 74, Issue 2, Page(s) 237–245

    Abstract: Background: Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection and persistent infection have been reported, but sequence characteristics in these scenarios have not been described. We assessed published cases of SARS-CoV-2 ... ...

    Abstract Background: Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection and persistent infection have been reported, but sequence characteristics in these scenarios have not been described. We assessed published cases of SARS-CoV-2 reinfection and persistence, characterizing the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
    Methods: A systematic review of PubMed was conducted to identify cases of SARS-CoV-2 reinfection and persistence with available sequences. Nucleotide and amino acid changes in the reinfecting sequence were compared with both the initial and contemporaneous community variants. Time-measured phylogenetic reconstruction was performed to compare intrahost viral evolution in persistent SARS-CoV-2 to community-driven evolution.
    Results: Twenty reinfection and 9 persistent infection cases were identified. Reports of reinfection cases spanned a broad distribution of ages, baseline health status, reinfection severity, and occurred as early as 1.5 months or >8 months after the initial infection. The reinfecting viral sequences had a median of 17.5 nucleotide changes with enrichment in the ORF8 and N genes. The number of changes did not differ by the severity of reinfection and reinfecting variants were similar to the contemporaneous sequences circulating in the community. Patients with persistent coronavirus disease 2019 (COVID-19) demonstrated more rapid accumulation of sequence changes than seen with community-driven evolution with continued evolution during convalescent plasma or monoclonal antibody treatment.
    Conclusions: Reinfecting SARS-CoV-2 viral genomes largely mirror contemporaneous circulating sequences in that geographic region, while persistent COVID-19 has been largely described in immunosuppressed individuals and is associated with accelerated viral evolution.
    MeSH term(s) COVID-19/therapy ; Humans ; Immunization, Passive ; Infant ; Phylogeny ; Reinfection ; SARS-CoV-2 ; COVID-19 Serotherapy
    Language English
    Publishing date 2021-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Systematic Review
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciab380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effects of dulaglutide on alcohol consumption during smoking cessation.

    Probst, Leila / Monnerat, Sophie / Vogt, Deborah R / Lengsfeld, Sophia / Burkard, Thilo / Meienberg, Andrea / Bathelt, Cemile / Christ-Crain, Mirjam / Winzeler, Bettina

    JCI insight

    2023  Volume 8, Issue 22

    Abstract: BACKGROUNDAlcohol use disorder has a detrimental impact on global health and new treatment targets are needed. Preclinical studies show attenuating effects of glucagon-like peptide-1 (GLP-1) agonists on addiction-related behaviors in rodents and nonhuman ...

    Abstract BACKGROUNDAlcohol use disorder has a detrimental impact on global health and new treatment targets are needed. Preclinical studies show attenuating effects of glucagon-like peptide-1 (GLP-1) agonists on addiction-related behaviors in rodents and nonhuman primates. Some trials have shown an effect of GLP-1 agonism on reward processes in humans; however, results from clinical studies remain inconclusive.METHODSThis is a predefined secondary analysis of a double-blind, randomized, placebo-controlled trial evaluating the GLP-1 agonist dulaglutide as a therapy for smoking cessation. The main objective was to assess differences in alcohol consumption after 12 weeks of treatment with dulaglutide compared to placebo. The effect of dulaglutide on alcohol consumption was analyzed using a multivariable generalized linear model.RESULTSIn the primary analysis, participants out of the cohort (n = 255) who reported drinking alcohol at baseline and who completed 12 weeks of treatment (n = 151; placebo n = 75, dulaglutide n = 76) were included. The median age was 42 (IQR 33-53) with 61% (n = 92) females. At week 12, participants receiving dulaglutide drank 29% less (relative effect = 0.71, 95% CI 0.52-0.97, P = 0.04) than participants receiving placebo. Changes in alcohol consumption were not correlated with smoking status at week 12.CONCLUSIONThese results provide evidence that dulaglutide reduces alcohol intake in humans and contribute to the growing body of literature promoting the use of GLP-1 agonists in treatment of substance use disorders.TRIAL REGISTRATIONClinicalTrials.gov NCT03204396.FUNDINGSwiss National Foundation, Gottfried Julia Bangerter-Rhyner Foundation, Goldschmidt-Jacobson Foundation, Hemmi Foundation, University of Basel, University Hospital Basel, Swiss Academy of Medical Science.
    MeSH term(s) Adult ; Female ; Humans ; Alcohol Drinking/drug therapy ; Diabetes Mellitus, Type 2/complications ; Glucagon-Like Peptide 1 ; Hypoglycemic Agents ; Smoking Cessation ; Double-Blind Method
    Chemical Substances dulaglutide (WTT295HSY5) ; Glucagon-Like Peptide 1 (89750-14-1) ; Hypoglycemic Agents
    Language English
    Publishing date 2023-11-22
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.170419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.

    Hooker, Stephanie A / Crain, A Lauren / LaFrance, Amy B / Kane, Sheryl / Fokuo, J Konadu / Bart, Gavin / Rossom, Rebecca C

    Addiction science & clinical practice

    2023  Volume 18, Issue 1, Page(s) 10

    Abstract: ... intentions both to get waivered (r = - 0.25, p = 0.03) and to prescribe buprenorphine with no waiver (r = - 0 ...

    Abstract Background: Many primary care clinicians (PCCs) hold stigma toward people with opioid use disorder (OUD), which may be a barrier to care. Few interventions exist to address PCC stigma toward people with OUD. This study examined whether an online training incorporating patient narratives reduced PCCs' stigma toward people with OUD (primary) and increased intentions to treat people with OUD compared to an attention-control training (secondary).
    Methods: PCCs from 15 primary care clinics were invited to complete a 30 min online training for an electronic health record-embedded clinical decision support (CDS) tool that alerts PCCs to screen, diagnose, and treat people with OUD. PCCs were randomized to receive a stigma-reduction version of the training with patient narrative videos or a control training without patient narratives and were blinded to group assignment. Immediately after the training, PCCs completed surveys of stigma towards people with OUD and intentions and willingness to treat OUD. CDS tool use was monitored for 6 months. Analyses included independent samples t-tests, Pearson correlations, and logistic regression.
    Results: A total of 162 PCCs were randomized; 88 PCCs (58% female; 68% white) completed the training (Stigma = 48; Control = 40) and were included in analyses. There was no significant difference between intervention and control groups for stigma (t = - 0.48, p = .64, Cohen's d = - 0.11), intention to get waivered (t = 1.11, p = .27, d = 0.26), or intention to prescribe buprenorphine if a waiver were no longer required (t = 0.90, p = 0.37, d = 0.21). PCCs who reported greater stigma reported lower intentions both to get waivered (r = - 0.25, p = 0.03) and to prescribe buprenorphine with no waiver (r = - 0.25, p = 0.03). Intervention group and self-reported stigma were not significantly related to CDS tool use.
    Conclusions: Stigma toward people with OUD may require more robust intervention than this brief training was able to accomplish. However, stigma was related to lower intentions to treat people with OUD, suggesting stigma acts as a barrier to care. Future work should identify effective interventions to reduce stigma among PCCs.
    Trial registration: ClinicalTrials.gov NCT04867382. Registered 30 April 2021-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT04867382.
    MeSH term(s) Humans ; Female ; Male ; Opiate Substitution Treatment ; Buprenorphine/therapeutic use ; Opioid-Related Disorders/drug therapy ; Surveys and Questionnaires ; Primary Health Care
    Chemical Substances Buprenorphine (40D3SCR4GZ)
    Language English
    Publishing date 2023-02-11
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2492632-2
    ISSN 1940-0640 ; 1940-0640
    ISSN (online) 1940-0640
    ISSN 1940-0640
    DOI 10.1186/s13722-023-00366-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Cumulative environmental stress and emerging cardiometabolic risk during childhood.

    Kunin-Batson, Alicia S / Haapala, Jacob / Crain, A Lauren / Gunnar, Megan R / Kharbanda, Elyse O / Kelly, Aaron S / Seburg, Elisabeth M / Sherwood, Nancy E / French, Simone A

    Pediatric obesity

    2024  , Page(s) e13116

    Abstract: ... 2-4 years old. Cardiometabolic risk factors (i.e., BMI, blood pressure, lipids, blood sugar, C ...

    Abstract Objective: To prospectively evaluate the relationship between cumulative environmental stress and cardiometabolic risk in middle childhood, and to examine whether hair cortisol, a measure of hypothalamic pituitary adrenal-axis activity, mediates this relationship.
    Methods: In a cohort of children from low-income households (n = 320; 59% Hispanic, 23% Black, body mass index (BMI) percentile >50th at enrollment), environmental stressors including family and neighbourhood factors representing disadvantage/deprivation, and cortisol concentrations from hair samples, were measured over five timepoints beginning when children were 2-4 years old. Cardiometabolic risk factors (i.e., BMI, blood pressure, lipids, blood sugar, C-reactive protein) were measured at the final timepoint when children were 7-11 years of age.
    Results: In adjusted logistic regression models, greater cumulative environmental stress was associated with a higher likelihood of elevated cardiometabolic risk in middle childhood (p = 0.01). Children from minoritized racial/ethnic groups had a higher prevalence of both stressors and cardiometabolic risk factors. Cumulative environmental stress was associated with higher hair cortisol concentrations (p < 0.01). However, hair cortisol was not directly associated with cardiometabolic risk factors and did not explain the association between environmental stress and cardiometabolic risk in causal mediation analysis.
    Conclusions: The influence of cumulative stress on cardiometabolic health can be observed in middle childhood and may contribute to cardiometabolic health disparities, highlighting the importance of public health interventions to mitigate disadvantage.
    Language English
    Publishing date 2024-03-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2655527-X
    ISSN 2047-6310 ; 2047-6302
    ISSN (online) 2047-6310
    ISSN 2047-6302
    DOI 10.1111/ijpo.13116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Protected Areas Established by Local Communities through Direct Democracy Encompass Habitat for Species as Effectively as Protected Areas Planned over Large Spatial Scales.

    Stachowiak, Chad / Crain, Benjamin J / Kroetz, Kailin / Sanchirico, James N / Armsworth, Paul R

    Environmental management

    2021  Volume 67, Issue 2, Page(s) 242–250

    Abstract: Local communities contribute to broader biodiversity protection goals when managing their immediate environment when they establish protected areas. However, their efforts are geographically constrained and often uncoordinated. We compare protected areas ...

    Abstract Local communities contribute to broader biodiversity protection goals when managing their immediate environment when they establish protected areas. However, their efforts are geographically constrained and often uncoordinated. We compare protected areas established by local communities through the direct democracy process in California, US, to protected areas created and managed by two conservation actors working over larger spatial scales, one private and one public. Despite being geographically constrained to smaller spatial scales, protected areas established by local communities were as effective as those established by larger scale conservation actors at representing different habitat types. However, local ballot protected areas tended to protect more common species. All three protected area networks often performed no better than random in terms of siting protected areas to support narrow range species and rare habitats. Improved accounting of local communities' protection efforts would allow organizations with greater funding flexibility to focus their efforts to increase representation of rarer species and habitats in protected area systems.
    MeSH term(s) Biodiversity ; Conservation of Natural Resources ; Democracy ; Ecosystem
    Language English
    Publishing date 2021-01-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1478932-2
    ISSN 1432-1009 ; 0364-152X
    ISSN (online) 1432-1009
    ISSN 0364-152X
    DOI 10.1007/s00267-020-01403-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pneumococcal Vaccines.

    Briles, D E / Paton, J C / Mukerji, R / Swiatlo, E / Crain, M J

    Microbiology spectrum

    2019  Volume 7, Issue 6

    Abstract: Streptococcus ... ...

    Abstract Streptococcus pneumoniae
    MeSH term(s) Animals ; Bacterial Proteins/administration & dosage ; Bacterial Proteins/genetics ; Bacterial Proteins/immunology ; Humans ; Pneumococcal Infections/immunology ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Pneumococcal Vaccines/immunology ; Streptococcus pneumoniae/genetics ; Streptococcus pneumoniae/immunology
    Chemical Substances Bacterial Proteins ; Pneumococcal Vaccines
    Language English
    Publishing date 2019-06-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2807133-5
    ISSN 2165-0497 ; 2165-0497
    ISSN (online) 2165-0497
    ISSN 2165-0497
    DOI 10.1128/microbiolspec.GPP3-0028-2018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Adopting artificial intelligence in dental education: A model for academic leadership and innovation.

    Islam, Nadim M / Laughter, Lory / Sadid-Zadeh, Ramtin / Smith, Carlos / Dolan, Teresa A / Crain, Geralyn / Squarize, Cristiane H

    Journal of dental education

    2022  Volume 86, Issue 11, Page(s) 1545–1551

    Abstract: Introduction: The continual evolution of dental education, dental practice and the delivery of optimal oral health care is rooted in the practice of leadership. This paper explores opportunities and challenges facing dental education with a specific ... ...

    Abstract Introduction: The continual evolution of dental education, dental practice and the delivery of optimal oral health care is rooted in the practice of leadership. This paper explores opportunities and challenges facing dental education with a specific focus on incorporating the use of artificial intelligence (AI).
    Methods: Using the model in Bolman and Deal's Reframing Organizations, the Four Frames model serves as a road map for building infrastructure within dental schools for the adoption of AI.
    Conclusion: AI can complement and boost human tasks and have a far-reaching impact in academia and health care. Its adoption could enhance educational experiences and the delivery of care, and support current functions and future innovation. The framework suggested in this paper, while specific to AI, could be adapted and applied to a myriad of innovations and new organizational ideals and goals within institutions of dental education.
    MeSH term(s) Humans ; Leadership ; Artificial Intelligence ; Delivery of Health Care ; Education, Dental
    Language English
    Publishing date 2022-07-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 410579-5
    ISSN 1930-7837 ; 0022-0337
    ISSN (online) 1930-7837
    ISSN 0022-0337
    DOI 10.1002/jdd.13010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top